Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | IDH2 | P48735 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12446470 | 0.89 | TRPV4 (0.34) | TRPV4CCR1RAB9ACCR5PDE4B | |
| SCHEMBL16502268 | 0.87 | CCR1 (0.62) | CCR1RAB9ACCR5PDE4BSLC40A1 | |
| SCHEMBL29829527 | 0.83 | LMNA (0.61) | CCR1CCR5SLC40A1KDM4EHSP90AA1 | |
| SCHEMBL29352384 | 0.82 | LMNA (0.59) | CCR1CCR5SLC40A1KDM4EHSP90AA1 | |
| SCHEMBL30690939 | 0.82 | LMNA (0.59) | CCR1CCR5SLC40A1KDM4EHSP90AA1 | |
| SCHEMBL3462719 | 0.80 | AURKA (0.41) | SLC40A1KDM4EPTGS2IDH1IDH2 | |
| SCHEMBL4968648 | 0.80 | PRKD3 (0.41) | RAB9AP2RX7NOTUMSLC40A1KDM4E | |
| SCHEMBL7253959 | 0.79 | METAP2 (0.53) | RAB9AKDM4EHSP90AA1HSD17B10 | |
| SCHEMBL8325687 | 0.79 | ELANE (0.41) | SLC40A1PTGS2IDH1IDH2 | |
| SCHEMBL30586451 | 0.79 | MAP4K4 (0.42) | RAB9ASLC40A1KDM4EPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080206890-A1 | BIS(2,9-DI-TERT-BUTYL-1,10-PHENANTHROLINE)COPPER(I) COMPLEXES, METHODS OF SYNTHESIS, AND USES THEROF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-08-28 | — | — | US | claimed |
| US-20110309304-A1 | LUMINESCENT SILVER COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110309304-A1 | LUMINESCENT SILVER COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110309304-A1 | LUMINESCENT SILVER COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| WO-2011152358-A1 | MEMBRANE CONTAINING SILVER COMPLEX | 住友化学株式会社 (JP) | 2011-12-08 | — | — | WO | disclosed |
| EP-2360162-A1 | LUMINESCENT SILVER COMPLEXES | Sumitomo Chemical Company, Limited (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-20080206890-A1 | BIS(2,9-DI-TERT-BUTYL-1,10-PHENANTHROLINE)COPPER(I) COMPLEXES, METHODS OF SYNTHESIS, AND USES THEROF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-08-28 | — | — | US | disclosed |
| US-6391648-B1 | ASSOCIATIONS FOR USE AS OPTICAL OXYGEN DETECTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206890-A1 | BIS(2,9-DI-TERT-BUTYL-1,10-PHENANTHROLINE)COPPER(I) COMPLEXES, METHODS OF SYNTHESIS, AND USES THEROF | TTI1, TTI2, TCOF1 | TRPV4 2526/4885CCR1 2095/4885RAB9A 1064/4885 |
| US-20110309304-A1 | LUMINESCENT SILVER COMPLEX | SOD1, AS3MT, GLO1 | TRPV4 1193/4885CCR1 4833/4885RAB9A 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.